ChromaDex Corporation (CDXC) Social Stream



ChromaDex Corporation (CDXC): $1.74

0.07 (+3.89%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CDXC to Watchlist
Sign Up

Industry: Chemicals


Ranked

of 90

in industry

ChromaDex Corp (CDXC) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CDXC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-02-10 4 $17 $12 $14.25 $2.58 452.33%
2022-03-08 5 $17 $7 $12.8 $2.58 396.12%
2022-03-10 5 $17 $7 $10.8 $2.58 318.6%

The Trend in the Analyst Price Target


CDXC's average price target has moved up $3.55 over the prior 22 months.

Over the past 49 weeks, CDXC's average upside potential has been 135.1%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 2 18 12 16.00 9.47 68.95%
2021-08-14 2 17 12 14.80 8.54 73.3%
2021-09-19 2 17 12 14.80 6.77 118.61%
2021-11-08 4 17 12 14.25 6.43 121.62%
2022-03-10 5 17 7 10.80 2.36 357.63%

CDXC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


CDXC's average broker recommendation rating improved by 0 over the prior 59 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CDXC as an investment opportunity.

  • ChromaDex Corp's upside potential (average analyst target price relative to current price) is higher than 379.42% of all US stocks.
  • CDXC has a higher average analyst price target than 52.56% of all US stocks.
  • ChromaDex Corp's variance in analysts' estimates is lower than -100.31% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, ChromaDex Corp's number of analysts covering the stock is higher than 133.4% of them.

Stocks similar to ChromaDex Corp in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VIVO, TRIB, and TKNO.

What is the outlook for CDXC? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5783 seconds.